| Patent | Date |
|---|
Pharmaceutical Formulations Containing Lipoic Acid Derivatives
App 20220184212 - Shorr; Robert G.L. ; et al. | 2022-06-16 |
Therapeutic Methods And Compositions For Treating Cancer Using 6,8-bis-benzylthio-octanoic Acid And An Autophagy Inhibitor
App 20220054445 - Pardee; Timothy S. ; et al. | 2022-02-24 |
Oral Therapy Using 6,8-bis-benzylthio-octanoic Acid
App 20220040133 - Shorr; Robert G.L. ; et al. | 2022-02-10 |
Therapeutic Methods And Compositions For Treating Pancreatic Cancer Using 6,8-bis-benzylthio-octanoic Acid
App 20210267922 - Luther; Sanjeev ; et al. | 2021-09-02 |
Methods of treating leukemia using compositions containing bis(benzylthio)octanoic acid and ion pairs thereof
Grant 11,065,335 - Shorr , et al. July 20, 2 | 2021-07-20 |
Therapeutic Methods And Compositions For Treating Prostate Cancer Using 6,8-bis-benzylthio-octanoic Acid
App 20210000778 - Luther; Sanjeev ; et al. | 2021-01-07 |
Pharmaceutical Formulations Containing Lipoic Acid Derivatives
App 20200009254 - Shorr; Robert G.L. ; et al. | 2020-01-09 |
Methods for treating cancer using 6,8-bis (benzylthio) octanonic acid
Grant 10,391,177 - Shorr , et al. A | 2019-08-27 |
Pharmaceutical Formulations Containing Lipoic Acid Derivatives
App 20190015512 - Shorr; Robert G.L. ; et al. | 2019-01-17 |
Pharmaceutical formulations containing lipoic acid derivatives
Grant 10,098,955 - Shorr , et al. October 16, 2 | 2018-10-16 |
Pharmaceutical Formulations Containing Lipoic Acid Derivatives
App 20180104341 - Shorr; Robert G. L. ; et al. | 2018-04-19 |
Methods of treating myeloma and lymphoma using compositions containing an ion pair of a lipoic acid derivative
Grant 9,872,845 - Shorr , et al. January 23, 2 | 2018-01-23 |
Methods of treating pancreatic and ovarian cancers using compositions containing an ion pair of a lipoic acid derivative
Grant 9,839,691 - Shorr , et al. December 12, 2 | 2017-12-12 |
Pharmaceutical Formulations Containing Lipoic Acid Derivatives
App 20170056355 - Shorr; Robert G. L. ; et al. | 2017-03-02 |
Pharmaceutical Formulations Containing Lipoic Acid Derivatives
App 20160220678 - Shorr; Robert G. L. ; et al. | 2016-08-04 |
Methods of treating colon, lung, and liver cancers using compositions containing an ion pair of a lipoic acid derivative
Grant 9,320,726 - Shorr , et al. April 26, 2 | 2016-04-26 |
Pharmaceutical Formulations Containing Lipoic Acid Derivatives
App 20150011633 - Shorr; Robert G. L. ; et al. | 2015-01-08 |
Pharmaceutical formulations containing lipoic acid derivatives
Grant 8,691,873 - Shorr , et al. April 8, 2 | 2014-04-08 |
Pharmaceutical Formulations Containing Lipoic Acid Derivatives
App 20130150445 - Shorr; Robert G. L. ; et al. | 2013-06-13 |
Pharmaceutical formulations containing lipoic acid derivatives
Grant 8,263,653 - Shorr , et al. September 11, 2 | 2012-09-11 |
Pharmaceutical Formulations Containing Lipoic Acid Derivatives
App 20120178812 - Shorr; Robert G.L. ; et al. | 2012-07-12 |
Pharmaceutical and diagnostic compositions containing nanoparticles useful for treating targeted tissues and cells
Grant RE43,295 - Shorr , et al. April 3, 2 | 2012-04-03 |
Pharmaceutical Formulations Containing Lipoic Acid Derivatives
App 20100190858 - Shorr; Robert G. L. ; et al. | 2010-07-29 |
Polyalkylene oxide-modified single chain polypeptides
Grant 7,632,504 - Whitlow , et al. December 15, 2 | 2009-12-15 |
Composition for maintaining organ and cell viability
Grant 7,537,885 - Fischer , et al. May 26, 2 | 2009-05-26 |
Pharmaceutical Formulations Containing Lipoic Acid Derivatives
App 20080262077 - SHORR; ROBERT G.L. ; et al. | 2008-10-23 |
Composition For Maintaining Organ And Cell Viability
App 20070178435 - Fischer; Joseph ; et al. | 2007-08-02 |
Composition for maintaining organ and cell viability
Grant 7,220,538 - Fischer , et al. May 22, 2 | 2007-05-22 |
Polyalkylene oxide-modified single chain polypeptides
Grant 7,150,872 - Whitlow , et al. December 19, 2 | 2006-12-19 |
Polyalkylene oxide-modified single chain polypeptides
Grant 6,872,393 - Whitlow , et al. March 29, 2 | 2005-03-29 |
Polyalkylene oxide-modified single chain polypeptides
App 20050048064 - Whitlow, Marc ; et al. | 2005-03-03 |
Composition for maintaining organ and cell viability
App 20050037330 - Fischer, Joseph ; et al. | 2005-02-17 |
Polyalkylene oxide-modified single chain polypeptides
App 20050008650 - Whitlow, Marc ; et al. | 2005-01-13 |
Polyalkylene oxide-modified single chain polypeptides
Grant 6,824,782 - Whitlow , et al. November 30, 2 | 2004-11-30 |
Polyalkylene oxide-modified single chain polypeptides
App 20020098192 - Whitlow, Marc ; et al. | 2002-07-25 |
Polyalkylene oxide-modified single chain polypeptides
App 20020061307 - Whitlow, Marc ; et al. | 2002-05-23 |
Alkyl or olefinic endcapped polyalkylene oxide solubilizer
Grant 6,013,283 - Greenwald , et al. January 11, 2 | 2000-01-11 |
Method of reducing side effects associated with administration of oxygen-carrying proteins
Grant 5,900,402 - Shorr May 4, 1 | 1999-05-04 |
Glycolipid enzyme-polymer conjugates
Grant 5,705,153 - Shorr , et al. January 6, 1 | 1998-01-06 |
Fractionated polyalkylene oxide-conjugated hemoglobin solutions
Grant 5,650,388 - Shorr , et al. July 22, 1 | 1997-07-22 |
Fractionation of polyalkylene oxide-conjugated hemoglobin solutions
Grant 5,478,805 - Shorr , et al. December 26, 1 | 1995-12-26 |
Site specific synthesis of conjugated peptides
Grant 5,428,128 - Mensi-Fattohi , et al. June 27, 1 | 1995-06-27 |
Process for hemoglobin extraction and purification
Grant 5,264,555 - Shorr , et al. November 23, 1 | 1993-11-23 |
| 